Evaluating anti-sickling therapies for sickle cell disease: a microfluidic assay for red blood cell-mediated microvascular occlusion under hypoxia
Open Access
- 2 October 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (23) , 6256-6267
Abstract
This study establishes the chemically induced hypoxia OcclusionChip assay as a reliable clinical tool for evaluating red blood cell deformability in sickle cell disease, with potential to improve personalized treatment strategies and outcomes.Keywords
Funding Information
- Small Business Innovation Research (R41HL172662, R42DK119048, R44HL140739)
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- American Society of Hematology
- Fogarty International Center (D43TW012260)
This publication has 44 references indexed in Scilit:
- Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell agingFrontiers in Physiology, 2014
- Microsphiltration: A Microsphere Matrix to Explore Erythrocyte Deformability2012
- Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusionJournal of Thrombosis and Haemostasis, 2011
- Sickle-cell diseaseThe Lancet, 2010
- Red blood cell-deformability measurement: Review of techniquesClinical Hemorheology and Microcirculation, 2009
- Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell diseaseBlood, 2006
- Reactive oxygen species and phosphatidylserine externalization in murine sickle red cellsBritish Journal of Haematology, 2004
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- [2] Ektacytometry of red blood cells1989
- Deformation of Red Blood Cells in CapillariesScience, 1969